Previous Article | Next Article ![]()
Journal of Clinical Microbiology, May 2004, p. 2282-2284, Vol. 42, No. 5
0095-1137/04/$08.00+0 DOI: 10.1128/JCM.42.5.2282-2284.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
Department of Microbiology, Toronto Medical Laboratories and Mount Sinai Hospital,1 University of Toronto,2 MDS Laboratories Inc.,3 Sunnybrook and Women's College Health Sciences Centre, Toronto, Ontario, Canada4
Received 30 November 2003/ Returned for modification 20 January 2004/ Accepted 10 February 2004
A prospective study of erythromycin and clindamycin resistance was performed with 304 consecutive group B streptococci (GBS) isolates. According to two automated susceptibility testing systems, Vitek-1 and Vitek-2, and double-disk agar diffusion, 79.9% were susceptible to both erythromycin and clindamycin. However, for macrolide-lincosamide-streptogramin B-inducible isolates, the accuracies of the Vitek-1 and Vitek-2 systems were 5.6 and 94.4%. In light of these results, we recommend that GBS be routinely tested using the double-disk diffusion method.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»